Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples (ALS-TDI PEG)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01948102 |
|
Recruitment Status :
Completed
First Posted : September 23, 2013
Last Update Posted : April 26, 2022
|
Sponsor:
Wake Forest University Health Sciences
Collaborator:
ALS Therapy Development Institute
Information provided by (Responsible Party):
Wake Forest University Health Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 6, 2014 |
| Actual Study Completion Date : | April 4, 2017 |